Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats

Probiotic yogurt improves antioxidant status in type 2 diabetic patients

(2011) Hanie S. Ejtahed et al.   NUTRITION

Human gut microbiota and its relationship to health and disease

(2011) Taylor C Wallace et al.   NUTRITION REVIEWS

Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects

(2010) Anne Sofie Andreasen et al.   BRITISH JOURNAL OF NUTRITION

Genetic control ofde novolipogenesis: role in diet-induced obesity

(2010) Maggie S. Strable et al.   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Estradiol Supplementation Helps Overcome Central Leptin Resistance of Ovariectomized Mice on a High Fat Diet

(2010) R. Matyšková et al.   HORMONE AND METABOLIC RESEARCH

Effect of Lactobacillus reuteri GMNL-263 treatment on renal fibrosis in diabetic rats

(2010) Ying-Chen Lu et al.   JOURNAL OF BIOSCIENCE AND BIOENGINEERING

Probiotics and prevention of allergic disease

(2009) Matthias V Kopp et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Effect ofLactobacillus gasseriBNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes

(2009) S.I. Yun et al.   JOURNAL OF APPLIED MICROBIOLOGY

Dietary Green Tea Extract Lowers Plasma and Hepatic Triglycerides and Decreases the Expression of Sterol Regulatory Element-Binding Protein-1c mRNA and Its Responsive Genes in Fructose-Fed, Ovariectomized Rats

(2009) Sudeep Shrestha et al.   JOURNAL OF NUTRITION

Superoxide production by mitochondria of insulin-sensitive tissues: mechanistic differences and effect of early diabetes

(2009) Judy A. Herlein et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Monitoring Bacterial Community of Human Gut Microbiota Reveals an Increase in Lactobacillus in Obese Patients and Methanogens in Anorexic Patients

(2009) Fabrice Armougom et al.   PLoS One

Insulin resistance is a cellular antioxidant defense mechanism

(2009) K. L. Hoehn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

(2008) Jing SHANG et al.   ACTA PHARMACOLOGICA SINICA

Mouse Elovl-6 promoter is an SREBP target

(2008) Shin Kumadaki et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Resveratrol inhibits nonalcoholic fatty liver disease in rats

(2008) Luis Bujanda et al.   BMC GASTROENTEROLOGY

The Metabolic Syndrome

(2008) Marc-Andre Cornier et al.   ENDOCRINE REVIEWS

Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding

(2008) P.D. Cani et al.   PATHOLOGIE BIOLOGIE